TABLE 2.
Clinical performance characteristics of the ResistancePlus MG kit in comparison to macrolide resistance status
| Macrolide resistance status | ResistancePlus MG kit characteristic(s)a |
|||||
|---|---|---|---|---|---|---|
| No. of results with presence of mutation | No. of results with no mutation | % sensitivity (95% CI) | % specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | |
| Presence of mutation | 21 | 1 | 95.4 (78.2–99.2) | 95.8 (88.3–98.5) | 87.5 (69.0–95.7) | 98.6 (92.2–99.7) |
| No mutation | 3 | 68 | ||||
a
CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value.